Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome：a Prospective, Multicenter, Non-randomized Controlled Intervention Study

NCT05604859 is registered in ClinicalTrials.gov with Qin Ning as lead sponsor.

NCT NCT05604859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05604859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome：a Prospective, Multicenter, Non-randomized Controlled Intervention Study
Lead sponsor
Qin Ning
Phase
Phase 4
Overall status
Unknown status
Start date
August 19, 2022
Completion date
June 30, 2024
Enrollment
350 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

severe fever with thrombocytopenia syndrome